)
Visual
test
Boule Diagnostics
Boule Diagnostics (BOUL) investor relations material
Boule Diagnostics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary24 Oct, 2025
Executive summary
Returned to organic growth of 1.7% in Q3, despite a 2.4% decline in reported net sales due to a 4.1% negative currency impact and ongoing market challenges.
Instrument sales grew 16–16.4% year-over-year, with strong demand for 5-part instruments and resumed government tenders.
Positive operating cash flow achieved for the second consecutive quarter, supported by a 30% reduction in operating expenses year-over-year.
Signed a technology partner supply agreement for a new veterinary instrument launching in 2026, supporting future growth.
Business now reported in two segments: Diagnostics and OEM, to enhance transparency and strategic focus.
Financial highlights
Q3 sales were SEK 127.2 million, down 2.4% year-over-year, but organic growth was positive at 1.7%.
Gross profit was SEK 52.4 million, with gross margin at 41.2% (down from 46.8% year-over-year, but up 2.4 points from Q2).
Adjusted EBIT reached SEK 12 million; adjusted operating margin was 9.4% (down from 11.8% year-over-year).
Operating cash flow improved to SEK 1 million from -11.6 million last year; available liquidity at quarter-end was SEK 37 million.
Operating expenses reduced by 30% year-over-year, reflecting restructuring and cost control.
Outlook and guidance
Expectation of sales stabilization as distributor inventories deplete and selective price increases to offset currency headwinds.
Positive outlook for the year, with continued focus on margin expansion, operational efficiency, and organic growth.
Ambition to maintain positive operating cash flow into 2025.
New product launches planned for 2026 and 2027, including generic blood control products.
One-off effects from delayed customer payments expected to decrease in coming quarters.
Future revenue impact of new product launches?
Currency headwind mitigation plans?
Further operational efficiency initiatives?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebPROV
Q2 FY2026 net income rose 65% year-over-year, with higher margins and strong credit quality. - 6 FebNVDA
AI-driven digital twins and accelerated computing are set to revolutionize industrial design and manufacturing. - 6 FebCDP
2025 FFO/share rose 5.8% to $2.72, with strong leasing and investment; 2026 guidance signals more growth. - 6 FebPECO
2026 FFO per share growth guided at 5.5% with record occupancy and robust acquisitions. - 6 FebCRI
Q1 2025 saw record revenue, a return to profit, and major new contracts in space technology. - 6 FebCRINet loss widened to 7.5m PLN in H1 2024 as revenue fell and R&D costs remained high.
- 6 FebCRINet loss deepened on lower sales and higher costs, but major new contracts and restructuring are underway.
- 6 FebEMBASSY
Record revenue, NOI, and distributions highlight strong growth and robust segment performance. - 6 FebCRIRevenue fell and losses deepened, but ESA contracts and R&D projects drive future prospects.
- 6 FebTUPRS
Net income reached TRY 29.5 billion, with strong dividends and a robust net cash position.
Next Boule Diagnostics earnings date
Q4 202511 Feb, 2026
Boule Diagnostics
Next Boule Diagnostics earnings date
Q4 202511 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Boule Diagnostics designs and manufactures instruments and consumables for use in laboratories around the globe to provide fast, accurate blood diagnostics. The company develops new technology platforms that offer improved speed, performance and reliability, broaden range and applicability of tests, and increase automation workflow efficiency through more effective diagnostics.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage